ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62,000 | -53.0% | 60,400 | -36.9% | 0.00% | – |
| Q2 2021 | $132,000 | -23.7% | 95,700 | -5.9% | 0.00% | – |
| Q1 2021 | $173,000 | +16.1% | 101,725 | +77.8% | 0.00% | – |
| Q4 2016 | $149,000 | +156.9% | 57,200 | +163.4% | 0.00% | – |
| Q2 2016 | $58,000 | -14.7% | 21,718 | -1.4% | 0.00% | – |
| Q1 2016 | $68,000 | -69.8% | 22,018 | -62.3% | 0.00% | – |
| Q4 2015 | $225,000 | +5.1% | 58,346 | +49.8% | 0.00% | – |
| Q3 2014 | $214,000 | -46.4% | 38,937 | 0.0% | 0.00% | – |
| Q2 2014 | $399,000 | -44.4% | 38,937 | -34.8% | 0.00% | – |
| Q1 2014 | $717,000 | – | 59,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |